Nyxoah (NASDAQ:NYXH) Stock Price Down 4.6% Following Weak Earnings

Key Points

• Nyxoah's stock price dropped 4.6% to $6.27 after a disappointing earnings report, where they missed earnings per share estimates by one cent.
• The company reported revenue of $1.58 million, exceeding analyst estimates of $1.33 million, despite a negative net margin of 1,541.84%.
• Stifel Nicolaus has reduced their price target for Nyxoah from $15.00 to $14.00 while maintaining a "buy" rating, as the stock currently holds an average target price of $15.00 from several analysts.

Shares of Nyxoah SA (NASDAQ:NYXH - Get Free Report) were down 4.6% during trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $6.27 and last traded at $6.27. Approximately 242,912 shares changed hands during mid-day trading, an increase of 63% from the average daily volume of 149,328 shares. The stock had previously closed at $6.57.

The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.62) by ($0.01). The company had revenue of $1.58 million during the quarter, compared to analyst estimates of $1.33 million. Nyxoah had a negative net margin of 1,541.84% and a negative return on equity of 74.13%.

Wall Street Analyst Weigh In

Separately, Stifel Nicolaus decreased their target price on Nyxoah from $15.00 to $14.00 and set a "buy" rating on the stock in a research note on Monday, April 21st. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $15.00.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in NYXH. Bank of America Corp DE raised its holdings in shares of Nyxoah by 72.4% in the 2nd quarter. Bank of America Corp DE now owns 7,866 shares of the company's stock valued at $59,000 after purchasing an additional 3,303 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Nyxoah in the second quarter valued at $70,000. LPL Financial LLC purchased a new stake in Nyxoah during the 4th quarter worth about $102,000. Walleye Capital LLC boosted its position in shares of Nyxoah by 23.9% during the 4th quarter. Walleye Capital LLC now owns 14,831 shares of the company's stock worth $119,000 after acquiring an additional 2,862 shares in the last quarter. Finally, Ameriprise Financial Inc. purchased a new position in shares of Nyxoah in the 4th quarter valued at about $135,000.

Nyxoah Stock Down 4.6%

The firm has a 50-day moving average price of $7.52 and a two-hundred day moving average price of $7.96. The firm has a market cap of $213.56 million, a price-to-earnings ratio of -2.73 and a beta of 1.61. The company has a debt-to-equity ratio of 0.22, a quick ratio of 3.35 and a current ratio of 3.59.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.